Peter Parker

Title: Innovations by Peter Parker

Introduction

Peter Parker is a notable inventor based in Ashstead, GB. He has made significant contributions to the field of biochemistry, particularly in the development of novel thiophosphorylating agents for therapeutic applications. With a total of 2 patents, his work has the potential to impact anti-tumor therapies significantly.

Latest Patents

Peter Parker's latest patents focus on the radio-labeling of proteins using nucleoside thiotriphosphates. These compounds carry ³²P in the gamma-thiophosphate group and are prepared through a reaction between a nucleoside diphosphate and a ³²P labeled thiophosphate salt. They serve as thiophosphorylating agents for antibodies that bind to tumor-associated antigens. The labeled thiotriphosphates can introduce a therapeutically useful ³²P atom into an antibody modified with a peptide region that acts as a substrate for a phosphokinase. The resulting labeled antibody can be used for injection in anti-tumor therapy, offering clinical advantages over the corresponding phosphorylated analogue.

Career Highlights

Peter Parker is currently employed at British Technology Group Limited, where he continues to innovate in the field of biochemistry. His work has garnered attention for its potential applications in cancer treatment, showcasing his commitment to advancing medical science.

Collaborations

Peter has collaborated with notable coworkers, including Brian Maurice Foxwell and Andrew M Creighton. Their combined expertise contributes to the innovative projects at British Technology Group Limited.

Conclusion

Peter Parker's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work in developing thiophosphorylating agents has the potential to revolutionize anti-tumor therapies, making a lasting impact on medical science.